Madhusudan Grover is a Gastroenterology physician affiliated with Mayo Clinic. OpenAlex indexes 292 publications with 9,062 citations (h-index 51); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 20 Dec 2023.
Clinical trials
- Fecal Microbiota Transplantation for IBS
Sponsor: Madhusudan (Madhu) Grover, MBBS
- PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Sponsor: Mayo Clinic
- Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Evoke Pharma, Inc.Program year20234 payments
- Evoke Pharma, Inc.Program year20224 payments
- Ardelyx, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)
Mayo Clinic Rochester
FY2026$322,800R01DK137800 - Microbiota based mechanisms of post-infection irritable bowel syndrome
Mayo Clinic Rochester
FY2025$349,800R01DK127998 - Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)
Mayo Clinic Rochester
FY2025$316,102R01DK137800
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review
Therapeutic Advances in Gastroenterology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”